Geoffroy Lapeyre

Co-founder and executive leader of Novostia, a Class III medical device start-up company developing a highly sophisticated and disruptive heart valve prosthesis, aimed at improving the quality of life of millions of people worldwide suffering from heart valve disease, especially young patients. • Revived and restructured a family project by establishing a Swiss company with solid corporate governance, financial, legal and risk management foundations • Raised €10M, incl. €3M non-dilutive funding from a highly selective EU program • Interacted with board members, shareholders, investors, and strategics • Actively participated in the company’s overall operations and business developement • Performed in-depth financial and market analysis, and developed effective regulatory & go-to-market strategies • Developed comprehensive cash flow forecasting and reporting • Made compelling pitch presentations to investors and partners • Built a team of 5 collaborators and developed partnerships with 30+ subcontractors, fostering a culture of trust, collaboration, and innovation • Successfully brought the technology from initial concept through clinical studies preparation

Relationship Manager & Business Developer (6 years), Collateral manager (4 years), Financial & risk analyst (2 years), active in Global Commodity Trade Finance & Structured Finance for large and mid-sized international trading companies. • Oversaw and developed a dynamic portfolio of 12+ global trading companies • Set up assets-based lending ranging from $5M to $2B, including L/C, RCF, PXF, Borrowing Base, Prefinancing, inventory financing, guarantees • Fostered growth and profitability through strong customer relationships, transactions origination & execution, and effective risk management • Performed extensive credit risk, financial, market, and compliance analysis • Made compelling credit applications & oral presentations to credit committees • Monitored transactions, collaterals, cash position, freight, and hedging • Collaborated effectively with various bank departments (compliance, risk, documentary credit, and legal)

Strategic and financial advisor of a family owned medical device company developing a highly sophisticated and disruptive heart valve prosthesis (Class III Medical Device), aimed at improving the quality of life of millions of people worldwide suffering from heart valve disease, especially young patients. • Participated in board meetings and initiated strategic reflections • Led fundraising activities and obtained 3 term sheets from different investors • Managed financial and legal matters • Developed detailed Business Plans (R&D, manufacturing, preclinical, clinical, regulatory,…) • Made investors presentations • Developed the company’s website

Financial Analyst active in corporate & investment banking for U.S. companies active in Aerospace & Defense, Paper & Packaging, Consumer Products. • Analyzed more than 10 large and mid-cap U.S. companies • Wrote credit research notes (market analysis, competition, strategy, financial statements, debt profile, collaterals, covenants) • Performed cash flow modeling • Coordinated with relationship managers, agent banks, lawyers, compliance, and risk management • Assisted senior bankers in visits to clients to generate cross-sells (Foreign Exchange, Interest Rate Swap, A/R Securitization)

Consultant at Ernst & Young Transactional Advisory Services active in Mergers & Acquisitions and Restructuring • Performed due diligence • Wrote private placement memorandums • Performed cash flow forecast modelling • Advised turnaround investments (wrote teasers, performed bidders research, evaluation of purchased assets, wrote biddings to the Court)

Mergers & Acquisitions Analyst – Internship • Wrote information memorandums • Prepared pitches • Performed targets and bidders' researches to generate M&A deals • Executed company valuation (Discounted Cash Flow, comparable methods) • Participated in due-diligence processes

B to B start-up aimed at Individual Financial Advisors